Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX, USA.
J Vasc Surg. 2013 Apr;57(4):1079-83. doi: 10.1016/j.jvs.2012.09.073. Epub 2013 Jan 11.
Local vancomycin treatment has been shown to decrease sternal wound complication rates. Whether a similar effect can be achieved at other surgical sites is unknown. This study investigates the effect of local vancomycin on inguinal wound complication rates after vascular procedures.
Retrospective analysis was performed on 454 patients who underwent open aortofemoral or infrainguinal vascular procedures between 2006 and 2011. Patients received preoperative systemic antibiotics either alone (group A) or in conjunction with intraoperative wound application of vancomycin powder and irrigation (group B). Inguinal wound infection and dehiscence over a 30-day period were recorded. Fisher exact test and multivariate regression analyses were performed.
There were 211 patients in group A and 243 patients in group B. Both groups had similar demographics and operative characteristics. There was a small but statistically significant decrease in the 30-day incidence of overall wound infections (25.1% vs 17.2%; P = .049) for group B patients. This was primarily due to a decreased rate in superficial infections (18.9% vs 11.5%; P = .033). No significant difference in the incidence of deep wound infections (6.1% vs 5.7%; P = .692) or overall dehiscence rates (22.2% vs 17.7%; P = .239) was detected. On multivariate analysis, history of chronic obstructive pulmonary disease and increased body mass index significantly increased risk of both infection and dehiscence. Medically optimized coronary artery disease was associated with less risk for dehiscence.
Addition of intraoperative local vancomycin did not improve the rates of inguinal wound dehiscence or deep infections but had a positive impact on superficial wound infections.
局部万古霉素治疗已被证明可降低胸骨伤口并发症的发生率。但在其他手术部位是否能达到类似效果尚不清楚。本研究旨在探讨局部万古霉素对血管手术后腹股沟伤口并发症发生率的影响。
回顾性分析了 2006 年至 2011 年间接受开放腹主动脉-股或下肢血管手术的 454 例患者。患者术前接受全身抗生素治疗(A 组)或全身抗生素治疗联合术中万古霉素粉末伤口应用和冲洗(B 组)。记录 30 天内腹股沟伤口感染和裂开的情况。采用 Fisher 确切检验和多变量回归分析。
A 组 211 例,B 组 243 例。两组患者的一般情况和手术特点相似。B 组患者 30 天内总伤口感染的发生率略有但具有统计学意义的降低(25.1%比 17.2%;P=0.049)。这主要是由于浅表感染率降低(18.9%比 11.5%;P=0.033)。两组深部感染(6.1%比 5.7%;P=0.692)或总裂开率(22.2%比 17.7%;P=0.239)无显著差异。多变量分析显示,慢性阻塞性肺疾病史和体重指数增加显著增加感染和裂开的风险。经医学优化的冠心病与裂开风险降低相关。
术中局部应用万古霉素并未提高腹股沟伤口裂开或深部感染的发生率,但对浅表伤口感染有积极影响。